|
US8263402B1
(en)
*
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US7410798B2
(en)
|
2001-01-10 |
2008-08-12 |
Geron Corporation |
Culture system for rapid expansion of human embryonic stem cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US20050042749A1
(en)
|
2001-05-16 |
2005-02-24 |
Carpenter Melissa K. |
Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
|
|
WO2001088104A2
(en)
|
2000-05-17 |
2001-11-22 |
Geron Corporation |
Neural progenitor cell populations
|
|
US7250294B2
(en)
|
2000-05-17 |
2007-07-31 |
Geron Corporation |
Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
|
|
US6897061B1
(en)
*
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
|
WO2003070171A2
(en)
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US7207743B2
(en)
*
|
2002-05-28 |
2007-04-24 |
Polivka Parking Solutions Llc |
Method and apparatus for constructing an automotive vehicle parking lot
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US7285415B2
(en)
|
2002-07-11 |
2007-10-23 |
The Regents Of The University Of California |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
AR046076A1
(es)
*
|
2003-07-18 |
2005-11-23 |
Otsuka Pharma Co Ltd |
Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida
|
|
US20050153446A1
(en)
*
|
2003-11-07 |
2005-07-14 |
Steindler Dennis A. |
Culturing and differentiating neural precursor cells
|
|
CA2560544C
(en)
|
2004-01-16 |
2015-05-19 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
NZ551832A
(en)
*
|
2004-06-09 |
2010-01-29 |
Univ Edinburgh |
Neural stem cells
|
|
CN101106955A
(zh)
*
|
2005-01-19 |
2008-01-16 |
菲迪亚高级生物聚合物有限公司 |
用于sci和pnt再生的透明质酸衍生物和神经干细胞
|
|
WO2008020815A1
(en)
|
2006-08-15 |
2008-02-21 |
Agency For Science, Technology And Research |
Mesenchymal stem cell conditioned medium
|
|
US7803364B2
(en)
*
|
2005-11-17 |
2010-09-28 |
The Cleveland Clinic Foundation |
Multipotent neural stem cells
|
|
WO2008054509A2
(en)
*
|
2006-04-14 |
2008-05-08 |
Celsense, Inc. |
Methods for assessing cell labeling
|
|
WO2007120911A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
WO2008055244A2
(en)
|
2006-10-31 |
2008-05-08 |
Sensient Colors Inc. |
Modified pigments and methods for making and using the same
|
|
CN101679951B
(zh)
*
|
2007-04-17 |
2013-09-11 |
罗切斯特大学 |
端脑胶质限制性细胞群和相关组合物及方法
|
|
CA2693678C
(en)
*
|
2007-07-10 |
2017-02-14 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
EP3483222A3
(en)
|
2007-08-23 |
2019-08-07 |
Sensient Colors LLC |
Self-dispersed pigments and methods for making and using the same
|
|
SG188096A1
(en)
|
2008-01-30 |
2013-03-28 |
Geron Corp |
Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
|
|
JP2011514169A
(ja)
|
2008-03-17 |
2011-05-06 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
幹細胞培養のためのマイクロキャリア
|
|
US20110110863A1
(en)
*
|
2008-05-02 |
2011-05-12 |
Celsense, Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
|
KR20110011658A
(ko)
|
2008-05-08 |
2011-02-08 |
유니버시티 오브 로체스터 |
최적화된 세포 제제에 의한 수초 질환의 치료
|
|
US9688956B2
(en)
|
2008-06-05 |
2017-06-27 |
National Cheng Kung University |
Method for preserving proliferation and differentiation potential of mesenchymal stem cells
|
|
US8669048B2
(en)
|
2008-06-24 |
2014-03-11 |
Parkinson's Institute |
Pluripotent cell lines and methods of use thereof
|
|
US20110236356A1
(en)
*
|
2008-12-12 |
2011-09-29 |
Nova Southeastern University |
Methods of isolating and using stem cells
|
|
EP3187581A1
(en)
|
2008-12-23 |
2017-07-05 |
BOCO Silicon Valley, Inc. |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
|
EP2417202A2
(en)
|
2009-04-07 |
2012-02-15 |
Sensient Colors LLC |
Self-dispersing particles and methods for making and using the same
|
|
WO2011011477A1
(en)
|
2009-07-21 |
2011-01-27 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
WO2011011500A1
(en)
|
2009-07-21 |
2011-01-27 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
WO2011096825A1
(en)
*
|
2010-02-05 |
2011-08-11 |
Auckland Uniservices Limited |
Cell programming
|
|
DK2539436T3
(da)
|
2010-02-25 |
2021-10-18 |
Abt Holding Co |
Modulering af makrofagaktivering
|
|
WO2012048276A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
US8433419B2
(en)
|
2010-10-13 |
2013-04-30 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlling neurostimulation according to physical state
|
|
PL2718416T3
(pl)
|
2011-06-06 |
2020-05-18 |
ReGenesys BVBA |
Namnażanie komórek macierzystych w bioreaktorach włóknisto-kapilarnych
|
|
JP6541577B2
(ja)
|
2013-02-06 |
2019-07-10 |
ユニバーシティー オブ ロチェスター |
ミエリン障害の治療のための誘導多能性細胞由来オリゴデンドロサイト前駆細胞
|
|
EP2970877B1
(en)
|
2013-03-15 |
2018-07-25 |
Wake Forest University Health Sciences |
Neural progenitor cell differentiation
|
|
IL289870B2
(en)
|
2013-04-12 |
2023-03-01 |
Lafrancesca Saverio |
Improving organs for transplantation
|
|
AU2014266935B2
(en)
|
2013-04-30 |
2020-06-11 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
|
WO2015073913A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
|
WO2017173064A1
(en)
|
2016-03-30 |
2017-10-05 |
Asterias Biotherapeutics, Inc. |
Oligodendrocyte progenitor cell compositions
|
|
EP4733316A3
(en)
*
|
2017-01-31 |
2026-05-06 |
Osaka University |
Differentiation control method for pluripotent stem cells
|
|
US11690876B2
(en)
|
2017-05-10 |
2023-07-04 |
University Of Rochester |
Methods of treating neuropsychiatric disorders
|
|
US12365872B2
(en)
|
2018-09-19 |
2025-07-22 |
Lineage Cell Therapeutics, Inc. |
Methods for differentiating pluripotent stem cells in dynamic suspension culture
|
|
KR20260020476A
(ko)
*
|
2019-01-23 |
2026-02-11 |
아스테리아스 바이오세라퓨틱스, 인크. |
인간 만능 줄기 세포로부터의 배측-유래된 희소돌기아교세포 전구 세포
|
|
JP7728747B2
(ja)
|
2019-08-23 |
2025-08-25 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
KR20220158046A
(ko)
|
2020-03-25 |
2022-11-29 |
사나 바이오테크놀로지, 인크. |
신경계 장애 및 병태의 치료를 위한 면역저하성 신경 세포
|
|
WO2022036150A1
(en)
|
2020-08-13 |
2022-02-17 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
US20240226164A1
(en)
|
2021-05-27 |
2024-07-11 |
Sana Biotechnology, Inc. |
Hypoimmunogenic cells comprising engineered hla-e or hla-g
|
|
KR20240046319A
(ko)
|
2021-07-14 |
2024-04-08 |
사나 바이오테크놀로지, 인크. |
저면역원성 세포에서의 y 염색체-연결 항원의 변경된 발현
|
|
US20240358761A1
(en)
|
2021-08-11 |
2024-10-31 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
EP4384598A1
(en)
|
2021-08-11 |
2024-06-19 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
|
JP2024535677A
(ja)
|
2021-08-11 |
2024-10-02 |
サナ バイオテクノロジー，インコーポレイテッド |
即時血液媒介性炎症反応を減少させるための同種細胞療法を目的とした遺伝子改変細胞
|
|
AU2022327174A1
(en)
|
2021-08-11 |
2024-02-15 |
Sana Biotechnology, Inc. |
Inducible systems for altering gene expression in hypoimmunogenic cells
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
|
WO2025054202A1
(en)
|
2023-09-05 |
2025-03-13 |
Sana Biotechnology, Inc. |
Method of screening a sample comprising a transgene with a unique barcode
|
|
WO2025151838A1
(en)
|
2024-01-12 |
2025-07-17 |
Sana Biotechnology, Inc. |
Safety switches to control in vitro and in vivo proliferation of cell therapy products
|